Titlebook: Brand Medicine; The Role of Branding Tom Blackett (deputy chairman),Rebecca Robins (sen Book 2001 Tom Blackett and Rebecca Robins 2001 Adve

投射

The valuation of pharmaceutical brandsSuch businesses have in the past amply repaid their investors, reflected in increased profits, dividends and share prices. The industry has relied for these profits on the ability of drug companies to pass on rising drug costs to the consumer in higher prices. This ability to charge high prices aris

CLAP

Direct-to-consumer branding — the US perspective patients or prospects to justify mass consumer spending over and above professional promotion. Those mass brands, in broad-reaching chronic care categories such as allergy, cardiology and metabolics as well as quality of life categories such as hair loss, developed an expertise in reaching and moti

MENT

Direct-to-consumer branding — Europe and Asiauch as Japan and Europe is an intensifying battleground for change. Advocate and reactionary interest groups continue to line up either side of the debate, which is complicated by the political and health professional conservatism that surrounds the business and economic arguments. Pressure is build

Alopecia-Areata

nurture

Public relations and its role in pharmaceutical brand buildingople, you will probably get different answers as to why this is the case: its credibility; its flexibility; its efficiency in using the mass media and the Internet; its utility as both a pre-launch and post-launch marketing tool in a regulated environment; its ability to cut through the clutter to r

penance

Pharmaceutical brand name developmente and wealth creation of an Rx brand. In the course of this chapter, I will set out to establish why the brand name is such a critical part of the branding mix and will look at the legal, linguistic and regulatory issues that need to be considered when developing a brand name for a new drug. I will

袖章

Arrhythmia

limber

藕床生厭倦